Giuseppe Giannini

7.8k total citations
109 papers, 4.1k citations indexed

About

Giuseppe Giannini is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Giuseppe Giannini has authored 109 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 37 papers in Cancer Research and 34 papers in Oncology. Recurrent topics in Giuseppe Giannini's work include Cancer Genomics and Diagnostics (24 papers), BRCA gene mutations in cancer (19 papers) and Colorectal Cancer Treatments and Studies (16 papers). Giuseppe Giannini is often cited by papers focused on Cancer Genomics and Diagnostics (24 papers), BRCA gene mutations in cancer (19 papers) and Colorectal Cancer Treatments and Studies (16 papers). Giuseppe Giannini collaborates with scholars based in Italy, United Kingdom and United States. Giuseppe Giannini's co-authors include Vincenzo Sorrentino, Alberto Gulino, Isabella Screpanti, Sandra Mammarella, Antonio Conti, Giulio Ratti, Rino Rappuoli, Lucia Di Marcotullio, Luigi Frati and Carlo Capalbo and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Giuseppe Giannini

107 papers receiving 4.0k citations

Peers

Countries citing papers authored by Giuseppe Giannini

Since Specialization

Citations

This map shows the geographic impact of Giuseppe Giannini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Giannini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Giannini more than expected).

Fields of papers citing papers by Giuseppe Giannini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe Giannini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Giannini. The network helps show where Giuseppe Giannini may publish in the future.

Co-authorship network of co-authors of Giuseppe Giannini

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe Giannini. A scholar is included among the top collaborators of Giuseppe Giannini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe Giannini. Giuseppe Giannini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	IFN-α Neutralizing Antibodies Distinguish LADA From Early-onset Type 1 Diabetes 2025 ·The Journal of Clinical Endocrinology & Metabolism ·(unknown), Luca D’Onofrio, (unknown), Stefano Di Giulio, Carmen Mignogna, (unknown), (unknown), Simona Zampetti, Ilaria Malandrucco, Paolo Pozzilli, Giuseppe Giannini, Ernesto Maddaloni, Raffaella Buzzetti	1
2	SMURF1 and SMURF2 directly target GLI1 for ubiquitination and proteasome-dependent degradation 2024 ·Cell Death Discovery ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Francesca Bufalieri, (unknown), (unknown), Giuseppe Giannini, Gianluca Canettieri, Lucia Di Marcotullio, Elisabetta Ferretti, Marta Moretti, Enrico De Smaele	1
3	MYC upstream region orchestrates resistance to PI3K inhibitors in cancer cells through FOXO3a-mediated autophagic adaptation 2024 ·Oncogene ·(unknown), (unknown), (unknown), (unknown), Miriam Gaggianesi, (unknown), (unknown), Francesca Bufalieri, (unknown), Enrico De Smaele, Giuseppe Giannini, Lucia Di Marcotullio, Alessandro Fatica, Giorgio Stassi, Laura Di Magno, Sonia Coni, Gianluca Canettieri	3
4	Prenatal Alcohol Exposure and Metabolic Disorders in Pediatrics: The Role of the Oxidative Stress—A Review of the Literature 2024 ·Children ·Martina Derme, (unknown), Mauro Ceccanti, Giuseppe Giannini, Mario Vitali, Marisa Patrizia Messina, Maria Grazia Piccioni, (unknown), (unknown), (unknown)	4
5	Exploring the utility of a NGS multigene panel to predict BCG response in patients with non-muscle invasive bladder cancer 2024 ·Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics ·(unknown), (unknown), (unknown), Chiara Nicolazzo, Giuseppe Giannini, Francesco Del Giudice, (unknown), Ettore De Berardinis, Luca Marino, Fabio Massimo Magliocca, Valentina Magri, (unknown), (unknown)	1
6	Genomic landscape and survival analysis of ctDNA “neo-RAS wild-type” patients with originally RAS mutant metastatic colorectal cancer 2023 ·Frontiers in Oncology ·Chiara Nicolazzo, Valentina Magri, Luca Marino, Francesca Belardinilli, Federica Di Nicolantonio, (unknown), S Caponnetto, (unknown), Giuseppe Giannini, Daniele Santini, Enrico Cortesi, Paola Gazzaniga	11
7	A gene dosage‐dependent effect unveils NBS1 as both a haploinsufficient tumour suppressor and an essential gene for SHH‐medulloblastoma 2022 ·Neuropathology and Applied Neurobiology ·Marialaura Petroni, Francesca Fabretti, Stefano Di Giulio, (unknown), (unknown), Marta Moretti, Francesca Belardinilli, Francesca Bufalieri, Anna Coppa, Paola Paci, Alessandro Corsi, Enrico De Smaele, Sonia Coni, Gianluca Canettieri, Lucia Di Marcotullio, Zhao‐Qi Wang, Giuseppe Giannini	4
8	RAS Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study 2022 ·Cancers ·Chiara Nicolazzo, Francesca Belardinilli, Annarita Vestri, Valentina Magri, (unknown), (unknown), S Caponnetto, Federica Di Nicolantonio, Enrico Cortesi, Giuseppe Giannini, Paola Gazzaniga	15
9	An integrative in-silico analysis discloses a novel molecular subset of colorectal cancer possibly eligible for immune checkpoint immunotherapy 2022 ·Biology Direct ·(unknown), Francesca Belardinilli, Valerio Licursi, Paola Paci, Giuseppe Giannini	7
10	Kras/ADAM17-Dependent Jag1-ICD Reverse Signaling Sustains Colorectal Cancer Progression and Chemoresistance 2019 ·Cancer Research ·Maria Pelullo, (unknown), (unknown), (unknown), Carmine Nicoletti, Zein Mersini Besharat, María Pía Felli, Bruna Cerbelli, Giulia d’Amati, Rocco Palermo, Carlo Capalbo, Claudio Talora, Lucia Di Marcotullio, Giuseppe Giannini, Saula Checquolo, Isabella Screpanti, Diana Bellavia	27
11	Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma 2017 ·Cancer Cell ·Veronica Veschi, Zhihui Liu, Ty C. Voss, Laurent Ozbun, Berkley E. Gryder, Chunhua Yan, Ying Hu, Anqi Ma, Jian Jin, Sharlyn J. Mazur, Norris Lam, Bárbara Kunzler Souza, Giuseppe Giannini, Gordon L. Hager, C.H. Arrowsmith, Javed Khan, Ettore Appella, Carol J. Thiele	72
12	MET Gene Amplification and MET Receptor Activation Are Not Sufficient to Predict Efficacy of Combined MET and EGFR Inhibitors in EGFR TKI-Resistant NSCLC Cells 2015 ·PLoS ONE ·Dario Presutti, (unknown), Beatrice Cardinali, Giuliana Papoff, (unknown), (unknown), (unknown), Giuseppe Giannini, Giovina Ruberti	20
13	NF-κB, and not MYCN, Regulates MHC Class I and Endoplasmic Reticulum Aminopeptidases in Human Neuroblastoma Cells 2010 ·Cancer Research ·Matteo Forloni, Sonia Albini, (unknown), Loredana Cifaldi, Renata Boldrini, Maria Rita Nicotra, Giuseppe Giannini, Pier Giorgio Natali, Patrizio Giacomini, Doriana Fruci	62
14	An Integrated Approach Identifies Nhlh1 and Insm1 as Sonic Hedgehog-regulated Genes in Developing Cerebellum and Medulloblastoma 2008 ·Neoplasia ·Enrico De Smaele, (unknown), Elisabetta Ferretti, Marianna Pelloni, Agnese Pò, Gianluca Canettieri, Sonia Coni, Lucia Di Marcotullio, Azzura Greco, Marta Moretti, Concezio Di Rocco, (unknown), Marella Maroder, Isabella Screpanti, Giuseppe Giannini, Alberto Gulino	41
15	Human Papilloma Virus-Dependent HMGA1 Expression Is a Relevant Step in Cervical Carcinogenesis 2008 ·Neoplasia ·Massimiliano Mellone, C Rinaldi, Isabella Massimi, Marialaura Petroni, Veronica Veschi, Claudio Talora, Silvia Truffa, Helena Stabile, Luigi Frati, Isabella Screpanti, Alberto Gulino, Giuseppe Giannini	15
16	Improving the accuracy of BRCA1/2 mutation prediction: validation of the novel country-customized IC software 2005 ·European Journal of Human Genetics ·Carlo Capalbo, Enrico Ricevuto, Annarita Vestri, (unknown), (unknown), Enrico Cortesi, Paolo Marchetti, Giovanni Scambia, Federica Tomao, C Rinaldi, Massimo Zani, S Ferraro, Luigi Frati, Isabella Screpanti, Alberto Gulino, Giuseppe Giannini	12
17	Human MRE11 is inactivated in mismatch repair‐deficient cancers 2002 ·EMBO Reports ·Giuseppe Giannini, (unknown), Fabio Cerignoli, C Rinaldi, Massimo Zani, Alessandra Viel, Laura Ottini, Marco Crescenzi, Stefano Martinotti, Margherita Bignami, Luigi Frati, Isabella Screpanti, Alberto Gulino	159
18	2-Aminopurine Unravels a Role for pRB in the Regulation of Gene Expression by Transforming Growth Factor β 1997 ·Journal of Biological Chemistry ·Giuseppe Giannini, Lucia Di Marcotullio, Francesca Zazzeroni, Edoardo Alesse, Massimo Zani, Anne Tang, Vincenzo Sorrentino, Isabella Screpanti, Luigi Frati, Alberto Gulino	6
19	Localization of a Novel Ryanodine Receptor Gene (RYR3) to Human Chromosome 15q14-q15 by in Situ Hybridization 1993 ·Genomics ·Vincenzo Sorrentino, Giuseppe Giannini, Perrine Malzac, Marie‐Geneviève Mattéi	28
20	Relative Increase of T Cells Expressing the Gamma/Delta Rather Than the Alpha/Beta Receptor in Ataxia-Telangiectasia 1990 ·New England Journal of Medicine ·Maurizio Carbonari, (unknown), (unknown), Giuseppe Giannini, Elena Galli, Carlo Gaetano, C Papetti, Massimo Fiorilli	92

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact